Literature DB >> 26414932

Human Induced Pluripotent Stem Cell NEUROG2 Dual Knockin Reporter Lines Generated by the CRISPR/Cas9 System.

Shenglan Li1,2, Haipeng Xue1,2, Jianbo Wu1,2, Mahendra S Rao3, Dong H Kim1,2, Wenbin Deng4,5, Ying Liu1,2,6.   

Abstract

Human induced pluripotent stem cell (hiPSC) technologies are powerful tools for modeling development and disease, drug screening, and regenerative medicine. Faithful gene targeting in hiPSCs greatly facilitates these applications. We have developed a fast and precise clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR associated protein 9 (Cas9) technology-based method and obtained fluorescent protein and antibiotic resistance dual knockin reporters in hiPSC lines for neurogenin2 (NEUROG2), an important proneural transcription factor. Gene targeting efficiency was greatly improved in CRISPR/Cas9-mediated homology directed recombination (∼ 33% correctly targeted clones) compared to conventional targeting protocol (∼ 3%) at the same locus. No off-target events were detected. In addition, taking the advantage of the versatile applications of the CRISPR/Cas9 system, we designed transactivation components to transiently induce NEUROG2 expression, which helps identify transcription factor binding sites and trans-regulation regions of human NEUROG2. The strategy of using CRISPR/Cas9 genome editing coupled with fluorescence-activated cell sorting of neural progenitor cells in a knockin lineage hiPSC reporter platform might be broadly applicable in other stem cell derivatives and subpopulations.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26414932      PMCID: PMC4683556          DOI: 10.1089/scd.2015.0131

Source DB:  PubMed          Journal:  Stem Cells Dev        ISSN: 1547-3287            Impact factor:   3.272


  78 in total

1.  Double nicking by RNA-guided CRISPR Cas9 for enhanced genome editing specificity.

Authors:  F Ann Ran; Patrick D Hsu; Chie-Yu Lin; Jonathan S Gootenberg; Silvana Konermann; Alexandro E Trevino; David A Scott; Azusa Inoue; Shogo Matoba; Yi Zhang; Feng Zhang
Journal:  Cell       Date:  2013-08-29       Impact factor: 41.582

2.  Targeted genome editing in human cells using CRISPR/Cas nucleases and truncated guide RNAs.

Authors:  Yanfang Fu; Deepak Reyon; J Keith Joung
Journal:  Methods Enzymol       Date:  2014       Impact factor: 1.600

3.  Genetic Modification in Human Pluripotent Stem Cells by Homologous Recombination and CRISPR/Cas9 System.

Authors:  Haipeng Xue; Jianbo Wu; Shenglan Li; Mahendra S Rao; Ying Liu
Journal:  Methods Mol Biol       Date:  2016

4.  Small molecules enhance CRISPR genome editing in pluripotent stem cells.

Authors:  Chen Yu; Yanxia Liu; Tianhua Ma; Kai Liu; Shaohua Xu; Yu Zhang; Honglei Liu; Marie La Russa; Min Xie; Sheng Ding; Lei S Qi
Journal:  Cell Stem Cell       Date:  2015-02-05       Impact factor: 24.633

5.  Oligodendrocyte and astrocyte development in rodents: an in situ and immunohistological analysis during embryonic development.

Authors:  Ying Liu; Yuanyuan Wu; Jeffrey C Lee; Haipeng Xue; Larysa H Pevny; Zaven Kaprielian; Mahendra S Rao
Journal:  Glia       Date:  2002-10       Impact factor: 7.452

6.  Functional properties of neurons derived from in vitro reprogrammed postnatal astroglia.

Authors:  Benedikt Berninger; Marcos R Costa; Ursula Koch; Timm Schroeder; Bernd Sutor; Benedikt Grothe; Magdalena Götz
Journal:  J Neurosci       Date:  2007-08-08       Impact factor: 6.167

7.  Gene targeting in a HUES line of human embryonic stem cells via electroporation.

Authors:  Katherine M Ruby; Binhai Zheng
Journal:  Stem Cells       Date:  2009-07       Impact factor: 6.277

8.  Rapid neurogenesis through transcriptional activation in human stem cells.

Authors:  Volker Busskamp; Nathan E Lewis; Patrick Guye; Alex H M Ng; Seth L Shipman; Susan M Byrne; Neville E Sanjana; Jernej Murn; Yinqing Li; Shangzhong Li; Michael Stadler; Ron Weiss; George M Church
Journal:  Mol Syst Biol       Date:  2014-11-17       Impact factor: 11.429

9.  Derivation and expansion using only small molecules of human neural progenitors for neurodegenerative disease modeling.

Authors:  Peter Reinhardt; Michael Glatza; Kathrin Hemmer; Yaroslav Tsytsyura; Cora S Thiel; Susanne Höing; Sören Moritz; Juan A Parga; Lydia Wagner; Jan M Bruder; Guangming Wu; Benjamin Schmid; Albrecht Röpke; Jürgen Klingauf; Jens C Schwamborn; Thomas Gasser; Hans R Schöler; Jared Sterneckert
Journal:  PLoS One       Date:  2013-03-22       Impact factor: 3.240

10.  Zinc Finger Targeter (ZiFiT): an engineered zinc finger/target site design tool.

Authors:  Jeffry D Sander; Peter Zaback; J Keith Joung; Daniel F Voytas; Drena Dobbs
Journal:  Nucleic Acids Res       Date:  2007-05-25       Impact factor: 16.971

View more
  6 in total

Review 1.  CRISPR/Cas9: at the cutting edge of hepatology.

Authors:  Francis P Pankowicz; Kelsey E Jarrett; William R Lagor; Karl-Dimiter Bissig
Journal:  Gut       Date:  2017-05-09       Impact factor: 23.059

2.  Establishing a dual knock-out cell line by lentivirus based combined CRISPR/Cas9 and Loxp/Cre system.

Authors:  Ya Li; Weifeng Zhang; Junli Zhao; Sai Li; Linlin Shan; Jiuling Zhu; Yan Li; He Zhu; Qinwen Mao; Haibin Xia
Journal:  Cytotechnology       Date:  2018-09-01       Impact factor: 2.058

3.  Human neural progenitors derived from integration-free iPSCs for SCI therapy.

Authors:  Ying Liu; Yiyan Zheng; Shenglan Li; Haipeng Xue; Karl Schmitt; Georgene W Hergenroeder; Jiaqian Wu; Yuanyuan Zhang; Dong H Kim; Qilin Cao
Journal:  Stem Cell Res       Date:  2017-01-05       Impact factor: 2.020

4.  One-Step piggyBac Transposon-Based CRISPR/Cas9 Activation of Multiple Genes.

Authors:  Shenglan Li; Anqi Zhang; Haipeng Xue; Dali Li; Ying Liu
Journal:  Mol Ther Nucleic Acids       Date:  2017-06-15       Impact factor: 8.886

5.  Direct visualization of the transition status during neural differentiation by dual-fluorescent reporter human pluripotent stem cells.

Authors:  Gwanghyun Park; Minkyung Shin; Wonyoung Lee; Akitsu Hotta; Taeko Kobayashi; Yoichi Kosodo
Journal:  Stem Cell Reports       Date:  2022-08-04       Impact factor: 7.294

Review 6.  Brain tumor modeling using the CRISPR/Cas9 system: state of the art and view to the future.

Authors:  Xiao-Yuan Mao; Jin-Xiang Dai; Hong-Hao Zhou; Zhao-Qian Liu; Wei-Lin Jin
Journal:  Oncotarget       Date:  2016-05-31
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.